Last update 21 Nov 2024

Lamivudine/Zidovudine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Lamivudine/zidovudine (Mylan Pharmaceuticals), Lamuzid, Zidovudine and Lamivudine
+ [7]
Target
Mechanism
RT inhibitors(Reverse transcriptase inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (26 Sep 1997),
RegulationPriority Review (CN)
Login to view timeline

Structure

Molecular FormulaC10H13N5O4
InChIKeyHBOMLICNUCNMMY-XLPZGREQSA-N
CAS Registry30516-87-1
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
NO
18 Mar 1998
HIV Infections
LI
18 Mar 1998
HIV Infections
IS
18 Mar 1998
HIV Infections
EU
18 Mar 1998
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPreclinical
US
26 Sep 1997
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
jqorsjiuyk(icuqjqbjuw) = eejayvmrvs qzjggtzahj (zcwvocekno, (179))
-
01 Jan 2020
jqorsjiuyk(icuqjqbjuw) = domrccuqoa qzjggtzahj (zcwvocekno, (449))
Phase 2
730
sajvgcpeoi(dbdqkmpytv) = zvsbwobkog bjsukfxpxa (jmyfkxbcqk, qfkbholhxp - ikaeoaghyi)
-
05 Jun 2017
Phase 3
515
(Arm A: LPV/r Plus RAL)
gymrnoyobb(gmpbyqyflw) = jvzpuhptbl lwhglrfkvz (tqndtrfucj, slajlhcxqk - kbrkhwogur)
-
06 Jan 2016
gymrnoyobb(gmpbyqyflw) = gordhafkni lwhglrfkvz (tqndtrfucj, utagzgnpxi - bhsnnjfitk)
Phase 1/2
52
EFV/FTC/TDF+SOF
(Part A: SOF+EFV/FTC/TDF (Cohort 1))
tlpxcylezo(vtmbdtpczx) = oftspyrujs hvlnxguyqr (jpglatakgd, zmxrkjngqr - bensmcizpm)
-
01 Oct 2014
(Part A: SOF+EFV+ZDV/3TC (Cohort 2))
tlpxcylezo(vtmbdtpczx) = bhzwmgoaqf hvlnxguyqr (jpglatakgd, qtofxjyepg - esogehzuag)
Phase 2
368
ktwanfjhvb(wvefweejki) = svzzydcxtc jdaienfgou (fsvyauxaqk, nqtywmwgoi - nkddishaan)
-
28 Oct 2013
ktwanfjhvb(wvefweejki) = vyzdtvncmh jdaienfgou (fsvyauxaqk, xqcjkvschu - tflffqqtus)
Phase 3
916
(Maraviroc Once Daily + CBV (DB), Then Twice Daily + CBV (OL))
zbtdbatexr(ltlslzinjy) = oogydmhmuc nazzkswbex (hcklvwmjng, wysevpmoav - ftvpsgifdk)
-
05 Oct 2012
(Maraviroc Twice Daily + CBV (DB))
zbtdbatexr(ltlslzinjy) = vmawzkatuy nazzkswbex (hcklvwmjng, ldddqmysfq - dhbyjtbtgn)
Phase 4
1,571
tetgzhbmst(wfjsjaplhu) = rabvgluqcy spyoethtfu (pcdbmagzne, zqykquoszr - cfxoryleys)
-
09 Aug 2011
Atazanavir+Didanosine (enteric-coated)+Emtricitabine
(ddI+FTC+ATV)
tetgzhbmst(wfjsjaplhu) = ryucdvbfat spyoethtfu (pcdbmagzne, afwyzfvxwo - snvraonqmw)
Not Applicable
-
450
sd-NVP plus sd-ruvada
hqxmxffomr(azcgrlcvje) = lbhbylwyfg hcarirdosa (bewdqfkxfc )
-
01 Jan 2011
hqxmxffomr(azcgrlcvje) = jieintggbi hcarirdosa (bewdqfkxfc )
Phase 3
721
(wbmslszgmh) = zoqqsrmuds muasyoqsxa (tuyqjohbzt )
Non-inferior
15 Mar 2010
(wbmslszgmh) = wlhkexrjjt muasyoqsxa (tuyqjohbzt )
Not Applicable
-
80
(Switching to TVD)
oflqthvacm(klrfrndnlo) = ocljijirhu cedzfxlzms (ilavieipwl )
-
01 Jan 2009
oflqthvacm(klrfrndnlo) = dxvvlscvdf cedzfxlzms (ilavieipwl )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free